Retractable syringes maker Unilife Corporation (UNIS) reported that it has developed the Unifill EZMix multiple-chamber ready-to-fill (prefilled) syringe for lyophilized (dried by freezing) drugs and vaccines requiring reconstitution. The Pennsylvania-based company is also patenting for the new device.
Unifill EZMix is the world’s first and only dual or multi-chamber prefilled syringe with a built-in safety mechanism. It comprises two or more drug containers within a single glass barrel to store liquid stable or lyophilized drugs and diluent for reconstitution. The device boasts of an automatic safety feature fully integrated within the glass barrel aimed at preventing healthcare workers from needle-stick injuries.
According to Unilife, the device will be marketed with either a fixed needle for drugs indicated for subcutaneous (under the skin) injections or with attachable needles (up to 1.5 inches in length).
Unifill EZMix has been geared to address the unmet needs of pharmaceutical and biotechnology companies for a convenient delivery system for the reconstitution and administration of lyophilized drugs and vaccines. The users can simply advance the plunger to mix the lyophilized powder with the diluent before swirling the syringe to complete reconstitution.
Prefilled syringes act as the device of choice for the administration of injectable vaccines and drugs that are marketed by over 20 pharmaceutical companies. Unilife is of the opinion that the pharma market for prefilled syringes is the most rapidly growing, relatively uncongested and most lucrative segment of the global syringe industry.
Unilife develops and markets advanced drug delivery systems. It collaborates with biotech and pharmaceutical companies and explores new devices that could be used with their drugs. The company has developed a wide array of its own injectable drug delivery products, including retractable syringes.
Unilife markets its prefilled syringes to pharmaceutical manufacturers, suppliers of medical products to healthcare facilities and patients who self-administer prescription drugs. Its patented syringes provide integrated safety, which is designed to protect patients from needle-stick injuries. Unilife competes with Becton, Dickinson and Company (BDX) among others.
BECTON DICKINSO (BDX): Free Stock Analysis Report
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment